Risk factors for the development of tinea pedis and onychomycosis: Real‐world evidence from a single‐podiatry center, large‐scale database in Japan

Onychomycosis and Tinea Pedis in the Feet of Patients With Diabetes

(2021) Javier Aragón-Sánchez et al.   International Journal of Lower Extremity Wounds

Onychomycosis: a review

(2020) Aditya K. Gupta et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Guidelines for the management of dermatomycosis (2019)

(2020) Takashi Mochizuki et al.   JOURNAL OF DERMATOLOGY

Point‐of‐care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy‐to‐use, prediction model

(2020) Hideki Kamiya et al.   Journal of Diabetes Investigation

Validity and Reliability of a Point-of-care Nerve Conduction Device in Diabetic Patients

(2019) Yuka Shibata et al.   Journal of Diabetes Investigation

Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study

(2018) Shinichi Watanabe et al.   JOURNAL OF DERMATOLOGY

Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study

(2017) Shinichi Watanabe et al.   JOURNAL OF DERMATOLOGY

Diagnosis and Management of Onychomycosis

(2016) Tracey C. Vlahovic et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy

(2014) Justin A. Lee et al.   PLoS One

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

(2012) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Epidemiology of diabetic foot problems and predictive factors for limb loss

(2008) Aziz Nather et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS